Double null cells reveal that CBP and p300 are dispensable for p53 targets p21 and Mdm2 but variably required for target genes of other signaling pathways

References

• Vo NK, Goodman RH. CBP and p300 in Transcriptional Regulation. J Biol Chem 2001; 276:13505 - 13508
   PubMed Web of Science ®Google Scholar
• Kalkhoven E. CBP and p300: HATs for different occasions. Biochem Pharmacol 2004; 68:1145 - 1155
   PubMed Web of Science ®Google Scholar
• Dekker FJ, Haisma HJ. Histone acetyl transferases as emerging drug targets. Drug Discov Today 2009; 14:942 - 948
   PubMed Web of Science ®Google Scholar
• Bedford DC, Kasper LH, Fukuyama T, Brindle PK. Target gene context influences the transcriptional requirement for the KAT3 family of CBP and p300 histone acetyltransferases. Epigenetics 2010; 5:9 - 15
   PubMed Web of Science ®Google Scholar
• Visel A, Blow MJ, Li Z, Zhang T, Akiyama JA, Holt A, et al. ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature 2009; 457:854 - 858
   PubMed Web of Science ®Google Scholar
• Kim TK, Hemberg M, Gray JM, Costa AM, Bear DM, Wu J, et al. Widespread transcription at neuronal activity-regulated enhancers. Nature 2010; 465:182 - 187
   PubMed Web of Science ®Google Scholar
• Allis CD, Berger SL, Cote J, Dent S, Jenuwien T, Kouzarides T, et al. New nomenclature for chromatin-modifying enzymes. Cell 2007; 131:633 - 636
   PubMed Web of Science ®Google Scholar
• Marmorstein R. Structure of histone acetyltransferases. J Mol Biol 2001; 311:433 - 444
   PubMed Web of Science ®Google Scholar
• Kasper LH, Lerach S, Wang J, Wu S, Jeevan T, Brindle PK. CBP/p300 double null cells reveal effect of coactivator level and diversity on CREB transactivation. EMBO J 2010; 29:3660 - 3672
   PubMed Web of Science ®Google Scholar
• Yao TP, Oh SP, Fuchs M, Zhou ND, Ch'ng LE, Newsome D, et al. Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 1998; 93:361 - 372
   PubMed Web of Science ®Google Scholar
• Oike Y, Takakura N, Hata A, Kaname T, Akizuki M, Yamaguchi Y, et al. Mice homozygous for a truncated form of CREB-binding protein exhibit defects in hematopoiesis and vasculo-angiogenesis. Blood 1999; 93:2771 - 2779
   PubMed Web of Science ®Google Scholar
• Kung AL, Rebel VI, Bronson RT, Ch'ng LE, Sieff CA, Livingston DM, et al. Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP. Genes Dev 2000; 14:272 - 277
   PubMed Web of Science ®Google Scholar
• Xu W, Fukuyama T, Ney PA, Wang D, Rehg J, Boyd K, et al. Global transcriptional coactivators CREB-binding protein and p300 are highly essential collectively but not individually in peripheral B cells. Blood 2006; 107:4407 - 4416
   PubMed Web of Science ®Google Scholar
• Kasper LH, Fukuyama T, Biesen MA, Boussouar F, Tong C, de Pauw A, et al. Conditional knockout mice reveal distinct functions for the global transcriptional coactivators CBP and p300 in T-cell development. Mol Cell Biol 2006; 26:789 - 809
   PubMed Web of Science ®Google Scholar
• Xu W, Kasper LH, Lerach S, Jeevan T, Brindle PK. Individual CREB-target genes dictate usage of distinct cAMP-responsive coactivation mechanisms. EMBO J 2007; 26:2890 - 2903
   PubMed Web of Science ®Google Scholar
• Brivanlou AH, Darnell JE Jr. Signal transduction and the control of gene expression. Science 2002; 295:813 - 818
   PubMed Web of Science ®Google Scholar
• Vousden KH, Prives C. Blinded by the Light: The Growing Complexity of p53. Cell 2009; 137:413 - 431
   PubMed Web of Science ®Google Scholar
• Gu W, Roeder RG. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 1997; 90:595 - 606
   PubMed Web of Science ®Google Scholar
• Gu W, Shi XL, Roeder RG. Synergistic activation of transcription by CBP and p53. Nature 1997; 387:819 - 823
   PubMed Web of Science ®Google Scholar
• Teufel DP, Freund SM, Bycroft M, Fersht AR. Four domains of p300 each bind tightly to a sequence spanning both transactivation subdomains of p53. Proc Natl Acad Sci USA 2007; 104:7009 - 7014
   PubMed Web of Science ®Google Scholar
• Ferreon JC, Lee CW, Arai M, Martinez-Yamout MA, Dyson HJ, Wright PE. Cooperative regulation of p53 by modulation of ternary complex formation with CBP/p300 and HDM2. Proc Natl Acad Sci USA 2009; 106:6591 - 6596
   PubMed Web of Science ®Google Scholar
• Lee CW, Ferreon JC, Ferreon AC, Arai M, Wright PE. Graded enhancement of p53 binding to CREB-binding protein (CBP) by multisite phosphorylation. Proc Natl Acad Sci USA 2010; 107:19290 - 19295
   PubMed Web of Science ®Google Scholar
• Lee CW, Martinez-Yamout MA, Dyson HJ, Wright PE. Structure of the p53 transactivation domain in complex with the nuclear receptor coactivator binding domain of CREB binding protein. Biochemistry 2010; 49:9964 - 9971
   PubMed Web of Science ®Google Scholar
• Coutts AS, La Thangue NB. The p53 response: emerging levels of co-factor complexity. Biochem Biophys Res Commun 2005; 331:778 - 785
   PubMed Web of Science ®Google Scholar
• Grossman SR, Perez M, Kung AL, Joseph M, Mansur C, Xiao ZX, et al. p300/MDM2 complexes participate in MDM2-mediated p53 degradation. Molecular Cell 1998; 2:405 - 415
   PubMed Web of Science ®Google Scholar
• Shi D, Pop MS, Kulikov R, Love IM, Kung AL, Grossman SR. CBP and p300 are cytoplasmic E4 polyubiquitin ligases for p53. Proc Natl Acad Sci USA 2009; 106:16275 - 16280
   PubMed Web of Science ®Google Scholar
• Sykes SM, Mellert HS, Holbert MA, Li K, Marmorstein R, Lane WS, et al. Acetylation of the p53 DNA-binding domain regulates apoptosis induction. Mol Cell 2006; 24:841 - 851
   PubMed Web of Science ®Google Scholar
• Natoli G, De Santa F. Shaping alternative NFkappaB-dependent gene expression programs: new clues to specificity. Cell Death Differ 2006; 13:693 - 696
   PubMed Web of Science ®Google Scholar
• Sen GC, Sarkar SN. Transcriptional signaling by double-stranded RNA: role of TLR3. Cytokine Growth Factor Rev 2005; 16:1 - 14
   PubMed Web of Science ®Google Scholar
• Panne D, Maniatis T, Harrison SC. An atomic model of the interferon-beta enhanceosome. Cell 2007; 129:1111 - 1123
   PubMed Web of Science ®Google Scholar
• Kim TK, Kim TH, Maniatis T. Efficient recruitment of TFIIB and CBP-RNA polymerase II holoenzyme by an interferon-beta enhanceosome in vitro. Proc Natl Acad Sci USA 1998; 95:12191 - 12196
   PubMed Web of Science ®Google Scholar
• Merika M, Williams AJ, Chen G, Collins T, Thanos D. Recruitment of CBP/p300 by the IFNbeta enhanceosome is required for synergistic activation of transcription. Mol Cell 1998; 1:277 - 287
   PubMed Web of Science ®Google Scholar
• Ford E, Thanos D. The transcriptional code of human IFNbeta gene expression. Biochim Biophys Acta 2010; 1799:328 - 336
   PubMed Web of Science ®Google Scholar
• Libermann TA, Baltimore D. Activation of interleukin-6 gene expression through the NFkappaB transcription factor. Mol Cell Biol 1990; 10:2327 - 2334
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Negishi H, Asagiri M, Nakajima C, Mizutani T, Takaoka A, et al. Essential role of IRF-3 in lipopolysaccharide-induced interferon-beta gene expression and endotoxin shock. Biochem Biophys Res Commun 2003; 306:860 - 866
   PubMed Web of Science ®Google Scholar
• Takaoka A, Yanai H, Kondo S, Duncan G, Negishi H, Mizutani T, et al. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 2005; 434:243 - 249
   PubMed Web of Science ®Google Scholar
• Covic M, Hassa PO, Saccani S, Buerki C, Meier NI, Lombardi C, et al. Arginine methyltransferase CARM1 is a promoter-specific regulator of NFkappaB-dependent gene expression. EMBO J 2005; 24:85 - 96
   PubMed Web of Science ®Google Scholar
• Arsenian S, Weinhold B, Oelgeschlager M, Ruther U, Nordheim A. Serum response factor is essential for mesoderm formation during mouse embryogenesis. EMBO J 1998; 17:6289 - 6299
   PubMed Web of Science ®Google Scholar
• Treisman R. The serum response element. Trends Biochem Sci 1992; 17:423 - 426
   PubMed Web of Science ®Google Scholar
• Dalton S, Treisman R. Characterization of SAP-1, a protein recruited by serum response factor to the c-fos serum response element. Cell 1992; 68:597 - 612
   PubMed Web of Science ®Google Scholar
• Selvaraj A, Prywes R. Expression profiling of serum inducible genes identifies a subset of SRF target genes that are MKL dependent. BMC Mol Biol 2004; 5:13
   PubMed Web of Science ®Google Scholar
• Lee SM, Vasishtha M, Prywes R. Activation and repression of cellular immediate early genes by serum response factor cofactors. J Biol Chem 2010; 285:22036 - 22049
   PubMed Web of Science ®Google Scholar
• Posern G, Treisman R. Actin' together: serum response factor, its cofactors and the link to signal transduction. Trends Cell Biol 2006; 16:588 - 596
   PubMed Web of Science ®Google Scholar
• Miralles F, Posern G, Zaromytidou AI, Treisman R. Actin dynamics control SRF activity by regulation of its coactivator MAL. Cell 2003; 113:329 - 342
   PubMed Web of Science ®Google Scholar
• Gineitis D, Treisman R. Differential usage of signal transduction pathways defines two types of serum response factor target gene. J Biol Chem 2001; 276:24531 - 24539
   PubMed Web of Science ®Google Scholar
• Ramirez S, Ait-Si-Ali S, Robin P, Trouche D, Harel-Bellan A, Ait S, Ali S. The CREB-binding protein (CBP) cooperates with the serum response factor for transactivation of the c-fos serum response element. J Biol Chem 1997; 272:31016 - 31021
   PubMed Web of Science ®Google Scholar
• Janknecht R, Nordheim A. Regulation of the c-fos promoter by the ternary complex factor Sap-1a and its coactivator CBP. Oncogene 1996; 12:1961 - 1969
   PubMed Web of Science ®Google Scholar
• Hanna M, Liu H, Amir J, Sun Y, Morris SW, Siddiqui MA, et al. Mechanical regulation of the proangiogenic factor CCN1/CYR61 gene requires the combined activities of MRTF-A and CREB-binding protein histone acetyltransferase. J Biol Chem 2009; 284:23125 - 23136
   PubMed Web of Science ®Google Scholar
• Stevens JL, Cantin GT, Wang G, Shevchenko A, Berk AJ. Transcription control by E1A and MAP kinase pathway via Sur2 mediator subunit. Science 2002; 296:755 - 758
   PubMed Web of Science ®Google Scholar
• Ravnskjaer K, Kester H, Liu Y, Zhang X, Lee D, Yates JR 3rd, et al. Cooperative interactions between CBP and TORC2 confer selectivity to CREB target gene expression. EMBO J 2007; 26:2880 - 2889
   PubMed Web of Science ®Google Scholar
• Mark M, Ghyselinck NB, Chambon P. Function of retinoic acid receptors during embryonic development. Nucl Recept Signal 2009; 7:2
   Google Scholar
• Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J 1996; 10:940 - 954
   PubMed Web of Science ®Google Scholar
• Chakravarti D, LaMorte VJ, Nelson MC, Nakajima T, Schulman IG, Juguilon H, et al. Role of CBP/P300 in nuclear receptor signalling. Nature 1996; 383:99 - 103
   PubMed Web of Science ®Google Scholar
• Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, et al. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 1996; 85:403 - 414
   PubMed Web of Science ®Google Scholar
• Balmer JE, Blomhoff R. Gene expression regulation by retinoic acid. J Lipid Res 2002; 43:1773 - 1808
   PubMed Web of Science ®Google Scholar
• Delacroix L, Moutier E, Altobelli G, Legras S, Poch O, Choukrallah MA, et al. Cell-specific interaction of retinoic acid receptors with target genes in mouse embryonic fibroblasts and embryonic stem cells. Mol Cell Biol 2010; 30:231 - 244
   PubMed Web of Science ®Google Scholar
• Jin Q, Yu LR, Wang L, Zhang Z, Kasper LH, Lee JE, et al. Distinct roles of GCN5/PCAF-mediated H3K9ac and CBP/p300-mediated H3K18/27ac in nuclear receptor transactivation. EMBO J 2010;
   PubMed Web of Science ®Google Scholar
• Koutroubas G, Merika M, Thanos D. Bypassing the requirements for epigenetic modifications in gene transcription by increasing enhancer strength. Mol Cell Biol 2008; 28:926 - 938
   PubMed Web of Science ®Google Scholar